Fate Therapeutics Inc Sustainability Reports
Fate Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders. The company utilizes a proprietary induced pluripotent stem cell platform to develop off-the-shelf cellular immunotherapies, including natural killer cell and T-cell product candidates.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300L14Q4UHOODLA90
FIGI: BBG001T888S2
12 reports from 2014 to 2025
